Hyaluronic Acid-Modified Cationic Lipid-PLGA Hybrid Nanoparticles as a Nanovaccine Induce Robust Humoral and Cellular Immune Responses

Lanxia Liu, Fengqiang Cao, Xiaoxuan Liu, Hai Wang, Chao Zhang, Hongfan Sun, Chun Wang, Xigang Leng, Cunxian Song, Deling Kong, Guilei Ma

Research output: Contribution to journalArticlepeer-review

85 Scopus citations

Abstract

Here, we investigated the use of hyaluronic acid (HA)-decorated cationic lipid-poly(lactide-co-glycolide) acid (PLGA) hybrid nanoparticles (HA-DOTAP-PLGA NPs) as vaccine delivery vehicles, which were originally developed for the cytosolic delivery of genes. Our results demonstrated that after the NPs uptake by dendritic cells (DCs), some of the antigens that were encapsulated in HA-DOTAP-PLGA NPs escaped to the cytosolic compartment, and whereas some of the antigens remained in the endosomal/lysosomal compartment, where both MHC-I and MHC-II antigen presentation occurred. Moreover, HA-DOTAP-PLGA NPs led to the up-regulation of MHC, costimulatory molecules, and cytokines. In vivo experiments further revealed that more powerful immune responses were induced from mice immunized with HA-DOTAP-PLGA NPs when compared with cationic lipid-PLGA nanoparticles and free ovalbumin (OVA); the responses included antigen-specific CD4+ and CD8+ T-cell responses, the production of antigen-specific IgG antibodies and the generation of memory CD4+ and CD8+ T cells. Overall, these data demonstrate the high potential of HA-DOTAP-PLGA NPs for use as vaccine delivery vehicles to elevate cellular and humoral immune responses.

Original languageEnglish (US)
Pages (from-to)11969-11979
Number of pages11
JournalACS Applied Materials and Interfaces
Volume8
Issue number19
DOIs
StatePublished - May 18 2016

Bibliographical note

Publisher Copyright:
© 2016 American Chemical Society.

Keywords

  • adjuvant
  • cationic lipid-PLGA hybrid nanoparticles
  • hyaluronic acid
  • immune response
  • vaccine

Fingerprint

Dive into the research topics of 'Hyaluronic Acid-Modified Cationic Lipid-PLGA Hybrid Nanoparticles as a Nanovaccine Induce Robust Humoral and Cellular Immune Responses'. Together they form a unique fingerprint.

Cite this